1. Home
  2. KNSA vs AMBA Comparison

KNSA vs AMBA Comparison

Compare KNSA & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • AMBA
  • Stock Information
  • Founded
  • KNSA 2015
  • AMBA 2004
  • Country
  • KNSA United Kingdom
  • AMBA United States
  • Employees
  • KNSA N/A
  • AMBA N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • AMBA Semiconductors
  • Sector
  • KNSA Health Care
  • AMBA Technology
  • Exchange
  • KNSA Nasdaq
  • AMBA Nasdaq
  • Market Cap
  • KNSA 2.6B
  • AMBA 3.0B
  • IPO Year
  • KNSA 2018
  • AMBA N/A
  • Fundamental
  • Price
  • KNSA $35.92
  • AMBA $82.64
  • Analyst Decision
  • KNSA Strong Buy
  • AMBA Strong Buy
  • Analyst Count
  • KNSA 6
  • AMBA 10
  • Target Price
  • KNSA $40.83
  • AMBA $93.44
  • AVG Volume (30 Days)
  • KNSA 392.6K
  • AMBA 1.2M
  • Earning Date
  • KNSA 10-28-2025
  • AMBA 08-28-2025
  • Dividend Yield
  • KNSA N/A
  • AMBA N/A
  • EPS Growth
  • KNSA N/A
  • AMBA N/A
  • EPS
  • KNSA 0.07
  • AMBA N/A
  • Revenue
  • KNSA $529,332,000.00
  • AMBA $348,051,000.00
  • Revenue This Year
  • KNSA $37.21
  • AMBA $35.94
  • Revenue Next Year
  • KNSA $11.99
  • AMBA $7.49
  • P/E Ratio
  • KNSA $542.28
  • AMBA N/A
  • Revenue Growth
  • KNSA 56.18
  • AMBA 57.91
  • 52 Week Low
  • KNSA $17.82
  • AMBA $38.86
  • 52 Week High
  • KNSA $37.34
  • AMBA $93.44
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 60.14
  • AMBA 63.32
  • Support Level
  • KNSA $35.29
  • AMBA $78.42
  • Resistance Level
  • KNSA $37.34
  • AMBA $86.76
  • Average True Range (ATR)
  • KNSA 1.00
  • AMBA 3.49
  • MACD
  • KNSA -0.15
  • AMBA -0.32
  • Stochastic Oscillator
  • KNSA 65.30
  • AMBA 39.56

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

Share on Social Networks: